HealthEquity (NASDAQ: HQY) EVP Fiore sells 2,470 shares in pre-set trade

Rhea-AI Filing Summary

HealthEquity, Inc. executive Michael Henry Fiore reported an open-market sale of 2,470 shares of Common Stock at $95.00 per share. The transaction left him holding 56,643 shares directly. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on October 14, 2025, indicating it was scheduled in advance rather than timed discretionarily.

Insights

Equity compensation and insider-trading analyst

Small, pre-planned insider sale; routine, neutral signal.

Executive vice president Michael Henry Fiore completed an open-market sale of 2,470 shares of HealthEquity, Inc. Common Stock at $95.00 per share. After the sale, he continues to hold 56,643 shares directly, indicating he maintains a substantial equity stake.

The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on October 14, 2025. Such plans pre-schedule trades, so the timing typically reflects portfolio management rather than a new view on the stock. With no derivative positions shown in this filing, the event appears routine and not thesis-changing.

Insider Trade Summary 10b5-1

Net Seller: 2,470 shares ($234,650)

Net Sell 1 txn

Insider Fiore Michael Henry

Role EVP, CHIEF COMMERCIAL OFFICER

Sold 2,470 shs ($235K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,470	$95.00	$235K

Holdings After Transaction: Common Stock — 56,643 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,470 shares Sale price: $95.00 per share Shares held after sale: 56,643 shares +3 more

6 metrics

Shares sold 2,470 shares Open-market sale of Common Stock

Sale price $95.00 per share Price for the 2,470-share sale

Shares held after sale 56,643 shares Direct ownership following transaction

Form type Form 4 Insider transaction report

Trading plan adoption date October 14, 2025 Rule 10b5-1 plan adoption

Transaction date July 2, 2026 Date of open-market sale

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Executive Vice President financial

"officer_title: EVP, CHIEF COMMERCIAL OFFICER"

An executive vice president is a high-ranking leader within a company who oversees major parts of its operations or strategies. Think of them as senior managers responsible for important areas, similar to a vice principal in a school hierarchy. Their role matters to investors because they help guide the company's success and decision-making at the top level.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 04:37 PM Accepted by SEC EDGAR 07/07/2026 - 04:36 PM Learn about SEC filing dates

FAQ

What did HealthEquity (HQY) executive Michael Fiore report in this Form 4?

Michael Henry Fiore reported an open-market sale of 2,470 shares of HealthEquity Common Stock at $95.00 per share. After the transaction, he directly holds 56,643 shares, indicating he retains a sizable ownership position in the company despite the sale.

How many HealthEquity (HQY) shares did Michael Fiore sell and at what price?

He sold 2,470 shares of HealthEquity Common Stock at a price of $95.00 per share. This was an open-market sale and represents only a portion of his overall holdings, as he still owns 56,643 shares directly after the transaction.

How many HealthEquity (HQY) shares does Michael Fiore hold after the transaction?

Following the reported sale, Michael Henry Fiore directly holds 56,643 shares of HealthEquity Common Stock. This figure comes after selling 2,470 shares in an open-market transaction at $95.00 per share disclosed in the Form 4 insider trading report.

Was Michael Fiore’s HealthEquity (HQY) share sale under a Rule 10b5-1 plan?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 14, 2025. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing as an indicator of insider sentiment.

What role does Michael Henry Fiore hold at HealthEquity (HQY)?

Michael Henry Fiore serves as Executive Vice President and Chief Commercial Officer at HealthEquity, Inc. His Form 4 filing reflects an open-market sale of 2,470 shares at $95.00 per share, after which he still directly owns 56,643 shares of Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fiore Michael Henry

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UTAH 84020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHIEF COMMERCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		S(1)		2,470	D	$95	56,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2025.

	/s/ Michael Fiore	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)